Vireo Growth Inc · CSE:VREO

Vireo Growth — Vireo Health — Investor Presentation (May 2019)

16 slides from Vireo Growth's investor presentation, May 13, 2019

  1. Slide 1: Corporate Presentation Spring 2019

    Corporate Presentation Spring 2019 CSE: VREO

  2. Slide 2: Disclaimer

    Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION: This document includes information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, referred to herein and which constitute “forward-lo

  3. Slide 3: Our Mission

    Our Mission “We are building the cannabis company of the future by bringing the best of science, medicine and engineering to the cannabis industry.” - Kyle Kingsley, M.D. Founder & CEO Our Mission || 3

  4. Slide 4: Leadership Team

    Leadership Team Kyle Kingsley, M.D. – Chief Executive Officer Amber Shimpa – Chief Financial Officer Dr. Kingsley is a board-certified emergency medicine physician, Amber has served as the Chief Financial Officer of Vireo entrepreneur, and inventor. Dr. Kingsley has a strong track Health since incep

  5. Slide 5: Corporate Timeline

    Corporate Timeline July 2014 June 2015 September 2015 May 2017 August 2017 July 2018 December 2018 March 2019 Broke ground on Awarded 1 of only 5 Midwest Hemp Launched first Participation in Awarded cultivation, Awarded 3 Retail Executed RTO Minnesota vertically integrated Research harvests first ca

  6. Slide 6: Vireo Strategy

    Vireo Strategy Opportunistic Best-in-Class Real Intellectual Growth Customer Experience Property Organic Growth Through Highly Professional Industrial Scale Process Merit-Based License Wins Retail Apparatus and Equipment Cost-Effective M&A Home Delivery Novel Proprietary Activity Cannabis Formulatio

  7. Slide 7: Vireo's Footprint

    Vireo’s Footprint MN MA NY RI PA NV OH CA MD AZ Current Footprint NM Binding Purchase & Sale Agreement(1) Subject to pending transactions Hemp assets Puerto Rico (1) Vireo expects this transaction to close during the second-quarter of 2019, subject to customary conditions of closing. Vireo’s Footpri

  8. Slide 8: State-by-State Snapshot of Operations

    State-by-State Snapshot of Operations (1) (1) (2) Minnesota New York Pennsylvania Maryland Ohio Rhode Island Arizona Puerto Rico Nevada Massachusetts New Mexico California Population 5.6 19.9 12.8 6.0 11.7 1.1 7.0 3.7 3.1 6.9 2.1 39.8 (MM) Purchase and Purchase and Status Current Current Current Cur

  9. Slide 9: Best-in-Class Customer Experience: Retail Dispensaries

    Best-in-Class Customer Experience: Retail Dispensaries Vireo’s retail outlets are being transformed and rebranded to “Green Goods” dispensaries, which will feature an inviting health and wellness environment, focused on personalized service Stock only the highest quality, safest products that have b

  10. Slide 10: Best-in-Class Customer Experience: Home Delivery & In-Store Pick-Up

    Best-in-Class Customer Experience: Home Delivery & In-Store Pick-Up Best-in-Class Customer Experience || 10

  11. Slide 11: Best In Class Customer Experience: Brands

    Best In Class Customer Experience: Brands Pharmaceutical-grade High Potency Products for High-Quality, Innovative Balanced, Comfortable, Products Geared Toward a Sophisticated Consumer Products for a Curious, Reliable Products for Patients Socially-Conscious Consumer Everyday Wellness Vireo Brands |

  12. Slide 12: Real Intellectual Property: Research Partners

    Real Intellectual Property: Research Partners Exclusive agreement to study the Randomized trial of medical Study to evaluate cannabis use IRB-approved research study to use of Captisol in the development cannabis in patients with newly among older adults – how they examine older adults’ use of and c

  13. Slide 13: Real Intellectual Property: Current Portfolio

    Real Intellectual Property: Current Portfolio Short Term Monetization Long-Term Applications Cannabis Moist Snuff Composition Harm Reduction Additive for Tobacco Products Multi-Channel Vaporizer Method for Treating Non-Cannabinoid Negative Control Antidepressant Withdrawal Formulations (Placebo) Syn

  14. Slide 14: Real Intellectual Property: Hemp

    Real Intellectual Property: Hemp Vireo is focused on the multi-billion dollar hemp market opportunity by developing combine-friendly, high- cannabinoid cannabis cultivars along with innovative consumer products. Midwest Hemp 1776 Hemp Research - Minnesota – New York Licensed to Cultivate and License

  15. Slide 15: Board of Directors

    Board of Directors Kyle Kingsley, M.D. – Chairman, Chief Executive Officer Amber Shimpa – Chief Financial Officer Dr. Kingsley is a board-certified emergency medicine physician, Amber has served as the Chief Financial Officer of Vireo entrepreneur, and inventor. Dr. Kingsley has a strong track Healt

  16. Slide 16: Slide 16

Vireo Health — Investor Presentation (May 2019) on 6ix